MK-677 vs HGH 191AA: Simple Research Comparison Guide
Two Different Roads to the Same Destination
Growth hormone research is a busy field. Two compounds come up constantly: MK-677 and HGH 191AA. They're often mentioned together, but they work in completely different ways. Let's break that down in plain English.
What Is MK-677?
MK-677 (also called Ibutamoren) is a growth hormone secretagogue. That's a fancy term for a compound that tells your pituitary gland — a pea-sized gland at the base of your brain — to release more of its own growth hormone. It mimics a hormone called ghrelin, sometimes nicknamed the "hunger hormone."
Crucially, MK-677 is taken orally — as a capsule or liquid. No injections needed. A landmark study found that 25 mg per day reversed diet-induced protein loss in healthy adults, improving nitrogen balance significantly compared to placebo.[1] Researchers have also explored its effects on bone turnover markers in elderly adults, finding increases after chronic oral administration.[6]
What Is HGH 191AA?
HGH 191AA stands for Human Growth Hormone, 191 amino acids. That "191AA" just tells you it's built from the same 191 amino acid chain as the growth hormone your body naturally makes. It is a synthetic, lab-produced version of the hormone itself — not a trigger, but the actual thing.
Unlike MK-677, HGH 191AA is administered by subcutaneous injection (a small shot under the skin). Because it is the hormone directly, its effects are more immediate and dose-dependent in a straightforward way.
Quick Side-by-Side Comparison
- Type: MK-677 = secretagogue (triggers release) | HGH 191AA = direct hormone replacement
- Route: MK-677 = oral | HGH 191AA = injection
- Research doses: MK-677 studies typically use 10–25 mg/day[1][4] | HGH 191AA research doses are measured in IU (International Units), commonly 1–4 IU per day in adult studies
- Onset: MK-677 raises GH levels within hours of a dose | HGH 191AA delivers the hormone directly, bypassing the pituitary
- Desensitization risk: Rat studies suggest MK-677's GH-stimulating effect can diminish over weeks of continuous use[3] | Direct HGH does not rely on the pituitary, so this mechanism doesn't apply
- Hunger effect: MK-677 commonly increases appetite (ghrelin mimicry) | HGH 191AA does not directly stimulate hunger
What Do the Studies Actually Show?
For MK-677, a case report found that a 25-year-old male using 15 mg/day alongside another compound saw significant changes in lean mass and biomarkers, but also notable drops in testosterone and HDL cholesterol during the cycle.[4] Another case flagged reversible liver enzyme elevation (hepatotoxicity) after two months of use.[2] A separate report linked MK-677 use — found undisclosed in a commercial supplement — to gynecomastia (breast tissue growth in males) and disrupted hormone levels, which resolved after stopping.[5]
These aren't reasons to panic, but they are reasons to read carefully and understand what researchers are actually measuring.
How to Use Our Dosing Charts
Both compounds have detailed, source-cited dosing data on this site. You can explore the MK-677 dosing chart to see how clinical studies structured their protocols, or head to the HGH 191AA chart for a breakdown of IU-based research dosing. If you want to convert units or compare figures side by side, our calculator tool makes that straightforward.
So Which Should You Read About?
That depends entirely on what research question you're exploring. Here's a simple guide:
- Interested in oral protocols and pituitary stimulation research? → Start with MK-677
- Interested in direct hormone replacement or deficiency studies? → Start with HGH 191AA
- Want to compare doses numerically? → Use the calculator
Neither compound is a magic bullet in the literature. Both show interesting effects and real risks. Reading the actual study data — not forum summaries — is always the best starting point.
This article is for educational and research reference purposes only. It is not medical advice. Always consult a qualified healthcare professional.
Sources
- MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism. — The Journal of clinical endocrinology and metabolism, 1998. PMID 9467534.
- Hepatotoxicity induced by MK-677. — BMJ case reports, 2025. PMID 40675653.
- Effect of the Orally Active Growth Hormone Secretagogue MK-677 on Somatic Growth in Rats. — Yonsei medical journal, 2018. PMID 30450851.
- LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report. — Experimental physiology, 2022. PMID 36303408.
- Reversible Gynecomastia and Hypogonadism Due to Usage of Commercial Performance-Enhancing Supplement Use. — JCEM case reports, 2024. PMID 39145153.
- Oral administration of the growth hormone secretagogue MK-677 increases markers of bone turnover in healthy and functionally impaired elderly adults. The MK-677 Study Group. — Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1999. PMID 10404019.